-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Breakdown: ADMA Biologics Q4

Benzinga·02/25/2026 21:12:28
Listen to the news

The earnings results for ADMA Biologics (NASDAQ:ADMA) for Q4 were made public on Wednesday, February 25, 2026 at 04:05 PM.

Here's a comprehensive overview of the announcement.

Earnings

ADMA Biologics beat estimated earnings by 7.5%, reporting an EPS of $0.215 versus an estimate of $0.2.

Revenue was up $21.61 million from the same period last year.

Previous Earnings Records

The company missed on EPS by $0.0 in the last quarter, resulting in a 8.72% drop share price change the following day.

Here's a look at ADMA Biologics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.16 0.14 0.14 0.15
EPS Actual 0.16 0.14 0.14 0.14
Revenue Estimate 130.36M 121.50M 116.40M 112.80M
Revenue Actual 134.22M 121.98M 114.80M 117.55M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.